ClassID:

20900

A61K38/08 - page 9 - CPC Classification

Classification description:

Medicinal preparations containing peptides; Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof Peptides having 5 to 11 amino acids

Recent Application in this class:
#2401
20130157936
2013-06-20

Modulation of ghrelin levels and ghrelin/unacylated ghrelin ratio using unacylated ghrelin

#2402
20130157931
2013-06-20

Mitochondrial penetrating peptides as carriers for antimicrobials

#2403
20130156704
2013-06-20

Therapy for subarachnoid hemorrhage and ischemia

#2404
20130150310
2013-06-13

Compositions and methods for treatment of cancer

#2405
20130150301
2013-06-13

Therapeutic agents for regulating serum phosphorus

#2406
20130143825
2013-06-06

COMPOUNDS FOR USE IN THE TREATMENT OF DISEASES BASED ON THE EXPRESSION OF TOXIC TRANSCRIPTS

#2407
20130143824
2013-06-06

COMPOSITIONS AND METHODS FOR ENHANCING APOPTOSIS

#2408
20130143823
2013-06-06

Compositions and methods of inhibiting apoptosis

#2409
20130143795
2013-06-06

METHOD OF TREATMENT OF HIV OR AIDS

#2410
20130143792
2013-06-06

Use of CHEC peptides to treat neurological and cardiovascular diseases and disorders

#2411
20130137641
2013-05-30

Methods for treating pain

#2412
20130137637
2013-05-30

Peptides for promoting angiogenesis and use thereof

#2413
20130130996
2013-05-23

Peptides for inhibiting chemokine binding to chemokine receptors

#2414
20130129621
2013-05-23

Integrin receptor antagonists and their methods of use

#2415
20130123464
2013-05-16

CEACAM based antibacterial agents

#2416
20130123190
2013-05-16

Methods for treating combined radiation and thermal injury

#2417
20130123186
2013-05-16

NEUROPROTECTION USING NAP-LIKE AND SAL-LIKE PEPTIDE MIMETICS

#2418
20130123174
2013-05-16

Neuritogenic peptides

#2419
20130122086
2013-05-16

Method for treating celiac disease

#2420
20130122031
2013-05-16

HMGB1-derived peptides enhance immune response to antigens

#2421
20130116195
2013-05-09

Binding ligand linked drug delivery conjugates of tubulysins

#2422
20130116193
2013-05-09

Use of the PAT nanopeptide in treating and preventing neurodegenerative diseases

#2423
20130116168
2013-05-09

Pea protein peptides with anti activity

#2424
20130115228
2013-05-09

Immunotherapy comprising TLR9 ligand and CD40 ligand

#2425
20130115226
2013-05-09

Methods and uses of TIE2 binding and/or activating agents

#2426
20130115196
2013-05-09

Hybrid hydrogel scaffold compositions and methods of use

#2427
20130115167
2013-05-09

Peptides that home to atherosclerotic plaques and methods of use

#2428
20130109632
2013-05-02

Use of a peptide fragment of CD44v6 in the treatment of ophthalmic diseases

#2429
20130109626
2013-05-02

Peptide and use thereof

#2430
20130108614
2013-05-02

Wound healing peptides and methods of use thereof

#2431
20130108575
2013-05-02

Antibacterial and antifungal peptides

#2432
20130102542
2013-04-25

CANCER RELATED ISOFORMS OF COMPONENTS OF TRANSCRIPTION FACTOR COMPLEXES AS BIOMARKERS AND DRUG TARGETS

#2433
20130102538
2013-04-25

METHOD OF TREATING ALZHEIMER'S DISEASE USING PHARMACOLOGICAL CHAPERONES TO INCREASE PRESENILIN FUNCTION AND GAMMA-SECRETASE ACTIVITY

#2434
20130102535
2013-04-25

Method for Preventing Myocardial Ischemia

#2435
20130102524
2013-04-25

Compounds and their use

#2436
20130096073
2013-04-18

Casein derived peptides and uses thereof

#2437
20130096070
2013-04-18

PEPTIDE TARGETING OF INNER EAR CELLS

#2438
20130095053
2013-04-18

Regulation of skin pigmentation by neuregulin-1 (NRG-1)

#2439
20130090289
2013-04-11

Method of treatment of type 2 diabetes

#2440
20130089525
2013-04-11

Antimicrobial compositions and methods of use thereof

#2441
20130084242
2013-04-04

Combinatorial therapies for the treatment of neoplasias using the opioid growth factor receptor

#2442
20130079289
2013-03-28

Pharmaceutical Compositions

#2443
20130072581
2013-03-21

Secreted protein acidic and rich in cysteine (SPARC) protein SRM assay

#2444
20130072475
2013-03-21

Compositions and methods for the treatment of asthma and associated disorders

#2445
20130072447
2013-03-21

ENHANCED ORAL TRANSCOMPARTMENTAL DELIVERY OF THERAPEUTIC OR DIAGANOSTIC AGENTS

#2446
20130072433
2013-03-21

Inhibitors of beta integrin-G protein alpha subunit binding interactions

#2447
20130072431
2013-03-21

Cardiovascular therapeutics

#2448
20130071411
2013-03-21

IAP BIR domain binding compounds

#2449
20130065837
2013-03-14

Integrin interaction inhibitors for the treatment of cancer

#2450
20130065830
2013-03-14

Amidated dopamine neuron stimulating peptide restoration of mitochondrial activity

#2451
20130060005
2013-03-07

COMPOSITIONS AND METHODS FOR INHIBITING THE INTERACTION BETWEEN CFTR AND CAL

#2452
20130059784
2013-03-07

Combination therapies using cyclosporine and aromatic cationic peptides

#2453
20130053321
2013-02-28

Inhibitors of mitochondrial fission and methods of use thereof

#2454
20130040898
2013-02-14

METHODS OF TREATMENT OF PATIENTS AT INCREASED RISK OF DEVELOPMENT OF ISCHEMIC EVENTS AND COMPOUNDS HEREOF

#2455
20130039972
2013-02-14

Compositions and methods of use of targeting peptides against placenta and adipose tissues

#2456
20130039851
2013-02-14

Stabilizing alkylglycoside compositions and methods thereof

#2457
20130034568
2013-02-07

METHODS OF TREATING OR PREVENTING PERIODONTITIS AND DISEASES ASSOCIATED WITH PERIODONTITIS

#2458
20130034519
2013-02-07

Peptidomimetic sulfamide compounds and antiviral uses thereof

#2459
20130029921
2013-01-31

Inhibiting peptides derived from TREM-like transcript 1 (TLT-1) and uses thereof

#2460
20130029910
2013-01-31

Method of treating prostate cancer with GnRH antagonist

#2461
20130022572
2013-01-24

Peptidomimetic sulfamide compounds and antiviral uses thereof

#2462
20130017229
2013-01-17

Active scaffolds for on-demand drug and cell delivery

#2463
20130014753
2013-01-17

Method of treating cancer with combinations of histone deacetylase inhibitors (HDAC1) substances

#2464
20130012451
2013-01-10

COMPOSITIONS AND METHODS FOR INHIBITING MMP-9-MEDIATED CELL MIGRATION

#2465
20130011338
2013-01-10

Cupredoxin derived transport agents and methods of use thereof

#2466
20130004941
2013-01-03

Proteinase K inhibitors, methods and compositions therefor

#2467
20130004415
2013-01-03

Joint-homing peptides and uses thereof

#2468
20120329718
2012-12-27

Methods for treating atrial or ventricular arrhythmias by administering a G-protein alpha inhibitor

#2469
20120329716
2012-12-27

Yellow pea seed protein-derived peptides

#2470
20120329712
2012-12-27

Induction of differential stress resistance and uses thereof

#2471
20120328666
2012-12-27

Oral delivery of peptide pharmaceutical compositions

#2472
20120323091
2012-12-20

Methods and apparatus for guiding medical care based on detected gastric function

#2473
20120322734
2012-12-20

Pharmaceutical Compositions Including Low Dosages of Desmopressin

#2474
20120316106
2012-12-13

SYNERGISTIC ANTIBIOTIC COMBINATIONS AND DERIVATIVES

#2475
20120316100
2012-12-13

Therapeutic use of peptide inhibitors of NADPH oxidase; aerosolization as a delivery mechanism

#2476
20120315279
2012-12-13

Method for inhibiting platelet derived growth factor signaling with C3aR or C5aR antibodies

#2477
20120315256
2012-12-13

USE OF TRANSFORMING GROWTH FACTOR - BETA 1 (TGF-B1) INHIBITOR PEPTIDES FOR THE TREATMENT OF CORNEAL FIBROSIS AND/OR HAZE

#2478
20120309938
2012-12-06

Hemiasterlin derivatives and uses thereof in the treatment of cancer

#2479
20120309696
2012-12-06

Methods of treating overproduction of cortisol using ACTH antagonist peptides

#2480
20120309677
2012-12-06

METHODS FOR REGULATING BLOOD GLUCOSE LEVELS

#2481
20120302504
2012-11-29

Method Of Reducing Injury To Mammalian Cells

#2482
20120282219
2012-11-08

Peptidomimetic protease inhibitors

#2483
20120276049
2012-11-01

Methods and compositions for amelioration of autoimmune disease using fusion proteins of anti-dendritic cell receptor antibody to peptide sequences

#2484
20120270790
2012-10-25

Compositions and methods for the treatment of myocardial ischemia/reperfusion injury with Annexin A1 short peptide

#2485
20120270768
2012-10-25

Tumor activated prodrugs

#2486
20120270767
2012-10-25

Tumor activated prodrugs

#2487
20120264681
2012-10-18

BUFFERED OPHTHALMIC COMPOSITIONS AND METHODS OF USE THEREOF

#2488
20120263759
2012-10-18

Depot stent comprising an elastin-based copolymer

#2489
20120252731
2012-10-04

Co-administration of an agent linked to an internalization peptide with an anti-inflammatory

#2490
20120244192
2012-09-27

SUSTAINED RELEASE FORMULATIONS OF PEPTIDOMIMETIC DRUGS AND USES THEREOF

#2491
20120238508
2012-09-20

Methods for promoting wound healing and/or reducing scar formation

#2492
20120232019
2012-09-13

Compositions and methods for treatment of eye disorders

#2493
20120225029
2012-09-06

Skin cream

#2494
20120225023
2012-09-06

Peptide protection against ultraviolet light toxicity

#2495
20120225013
2012-09-06

Anti-mesothelin antibodies and immunoconjugates

#2496
20120220536
2012-08-30

Use of endostatin peptides for the treatment of fibrosis

#2497
20120219537
2012-08-30

Method for repairing DNA damage in keratinocytes

#2498
20120219505
2012-08-30

Peptide reagents and methods for detection of colon dysplasia

#2499
20120219502
2012-08-30

METHODS AND COMPOSITIONS FOR TARGETING GC1QR/P32

#2500
20120214742
2012-08-23

GABA release-regulating agent in cerebellum

#2501
20120214729
2012-08-23

Composition for preventing or treating inflammation

#2502
20120214235
2012-08-23

Methods and compositions for treating neurodegenerative disorders and Alzheimer's disease and improving normal memory

#2503
20120208766
2012-08-16

TOPICAL CORNEAL ANALGESIA USING NEUROTENSIN RECEPTOR AGONISTS AND SYNERGISTIC NEUROTENSIN COMBINATIONS WITHOUT DELAYING WOUND HEALING

#2504
20120208764
2012-08-16

Method and compositions for treating stroke with fever

#2505
20120207789
2012-08-16

TOPICAL CORNEAL ANALGESIA USING NEUROTENSIN RECEPTOR AGONISTS AND SYNERGISTIC NEUROTENSIN COMBINATIONS WITHOUT DELAYING WOUND HEALING

#2506
20120207675
2012-08-16

Method of colorectal cancer detection by using radiolabeled anti-GRP78 peptide

#2507
20120202970
2012-08-09

Fragment ligated inhibitors selective for the polo box domain of PLK1

#2508
20120202744
2012-08-09

DUAL ANTAGONISM OF ENDOTHELIN TYPE A AND BRADYKININ B1 RECEPTORS FOR TREATING PAIN AND PREVENTING CARTILAGE DEGRADATION

#2509
20120202733
2012-08-09

Inhibition of TREM receptor signaling with peptide variants

#2510
20120195978
2012-08-02

CAPCNA PEPTIDE THERAPEUTICS FOR CANCER

#2511
20120195918
2012-08-02

Method of treating cancer with an HLA-A*3303-restricted WT1 peptide and pharmaceutical composition comprising the same

#2512
20120190624
2012-07-26

ψεrack peptide composition and method for protection against tissue damage due to ischemia

#2513
20120190622
2012-07-26

Inhibitors of the epidermal growth factor receptor-heat shock protein 90 binding interaction

#2514
20120190614
2012-07-26

HCV protease inhibitors and uses thereof

#2515
20120190611
2012-07-26

Method for treatment of inflammatory disease and disorder

#2516
20120189682
2012-07-26

Inhibition of biofilm organisms

#2517
20120184490
2012-07-19

Enhancement of bone morphogenic protein (BMP) retention with BMP binding peptide (BBP)

#2518
20120183580
2012-07-19

Analgesic Composition for Transbuccal Administration

#2519
20120183546
2012-07-19

TREATMENT OF OVARIAN CANCER USING A SPECIFIC BINDING AGENT OF HUMAN ANGIOPOIETIN-2 IN COMBINATION WITH A TAXANE

#2520
20120178667
2012-07-12

METHODS FOR TREATING SEPTIC SHOCK

#2521
20120172310
2012-07-05

Treatment of cancers with A-8R peptide

#2522
20120172302
2012-07-05

COMPOSITION FOR THE TREATMENT OF BENIGN PROSTATE HYPERPLASIA

#2523
20120172285
2012-07-05

Methods and compositions for specific modulation of MCL-1

#2524
20120171210
2012-07-05

METHODS AND COMPOSITIONS FOR INHIBITING C-MET DIMERIZATION AND ACTIVATION

#2525
20120165250
2012-06-28

Active cores of peptide triazole HIV-1 entry inhibitors

#2526
20120156276
2012-06-21

Connective tissue stimulating peptides

#2527
20120156180
2012-06-21

COMPOSITIONS AND METHODS FOR THE TREATMENT OF KRABBE AND OTHER NEURODEGENERATIVE DISEASES

#2528
20120149634
2012-06-14

Compounds and methods for treating bone disorders and controlling weight

#2529
20120148673
2012-06-14

Peptides that down regulate the activity of plasma membrane transporters including sodium-D-glucose cotransporter SGLT1

#2530
20120142615
2012-06-07

Methods related to the treatment of neurodegenerative and inflammatory conditions

#2531
20120135918
2012-05-31

Methods of inhibiting the ghrelin/growth hormone secretatogue receptor pathway and uses thereof

#2532
20120135917
2012-05-31

Anti-Gram Negative Bacteria Agent

#2533
20120129792
2012-05-24

AGENT FOR ELIMINATING MULTIDRUG RESISTANCE

#2534
20120129791
2012-05-24

Stimulator of genital, sexual and reproductive function

#2535
20120129776
2012-05-24

Peptide ligands for G-protein coupled receptors

#2536
20120128755
2012-05-24

Personal Care Composition Containing Yeast Extract And Hexapeptide

#2537
20120128696
2012-05-24

Methods for detecting and inhibiting angiogenesis

#2538
20120128683
2012-05-24

AUTISM TREATMENT

#2539
20120128581
2012-05-24

Sincalide Formulations

#2540
20120122893
2012-05-17

Methods of treating cancer

#2541
20120122790
2012-05-17

Methods for the treatment of X-linked hypophosphatemia and related disorders

#2542
20120122786
2012-05-17

Method for treating myocardial ischemia

#2543
20120121706
2012-05-17

PAR-1 Activation by Metalloproteinase-1 (MMP-1)

#2544
20120121675
2012-05-17

Peptide-based compounds and compositions which inhibit muscle contraction

#2545
20120115794
2012-05-10

USE OF CD44V6 IN THE TREATMENT OF OPHTHALMIC DISEASES

#2546
20120114681
2012-05-10

Use of specific peptides in the preparation of a medicament for the treatment of monoclonal gammopathy of undetermined significance (MGUS) or of smoldering multiple myeloma (SMM)

#2547
20120114673
2012-05-10

COMPOSITIONS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF TUMOR

#2548
20120114669
2012-05-10

Compositions and method for the diagnosis, prevention and treatment of alzheimer's disease

#2549
20120108520
2012-05-03

Method of treating tumors

#2550
20120108502
2012-05-03

Anti-parasitic compounds

#2551
20120107337
2012-05-03

Formulations of tumour-associated peptides binding to human leukocyte antigen (HLA) class I or class II molecules for vaccines

#2552
20120100086
2012-04-26

Proteasome-activating lightening peptidic hydrolyzates and compositions containing them

#2553
20120094921
2012-04-19

Cosmetic and/or pharmaceutical composition comprising a relieving peptidic hydrolyzate

#2554
20120094920
2012-04-19

Cosmetic and/or pharmaceutical composition comprising a peptidic hydrolyzate that can reinforce the barrier function

#2555
20120093919
2012-04-19

E2F as a target of hormone refractory prostate cancer

#2556
20120093886
2012-04-19

Pharmaceutical compositions and related methods of delivery

#2557
20120083452
2012-04-05

Topical Anesthetic Uses of Szeto-Schiller Peptides

#2558
20120083451
2012-04-05

Composition for improving brain function and method for improving brain function

#2559
20120082700
2012-04-05

Compositions for stimulation of mammalian innate immune resistance to pathogens

#2560
20120082671
2012-04-05

Modulation of activity of neurotrophins

#2561
20120077755
2012-03-29

Compounds for, and methods of, treating cancer and inhibiting invasion and metastases

#2562
20120077745
2012-03-29

Method of stimulating the motility of the gastrointestinal system using growth hormone secretagogues

#2563
20120076861
2012-03-29

Materials and methods for the treatment of celiac disease

#2564
20120076809
2012-03-29

METHOD TO INHIBIT THE BIOLOGICAL ACTIVITY OF CALCINEURIN WITH SELECTIVE PEPTIDES

#2565
20120071538
2012-03-22

Methods of treatment using orodispersible desmopressin pharmaceutical formulations

#2566
20120071411
2012-03-22

LKKTET and/or LKKTNT peptide compositions which are lyophilized or in a form capable of being lyophilized

#2567
20120071399
2012-03-22

Sulfation of Wnt pathway proteins

#2568
20120071397
2012-03-22

Methods for Hematopoietic Stem Cell Transplantation

#2569
20120071396
2012-03-22

Compositions and methods for inhibiting the interaction between CFTR and CAL

#2570
20120065131
2012-03-15

COMPOSITIONS AND METHODS FOR TOPICAL APPLICATION AND TRANSDERMAL DELIVERY OF AN OLIGOPEPTIDE

#2571
20120064125
2012-03-15

AGR-MEDIATED INHIBITION OF METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS

#2572
20120064034
2012-03-15

Peptidomimetic protease inhibitors

#2573
20120060834
2012-03-15

Pharmaceutical preparation to be administered into respiratory organs for treating or preventing inflammatory respiratory diseases, and method for treating or preventing such diseases

#2574
20120058953
2012-03-08

COMPOSITIONS AND METHODS FOR ENHANCING APOPTOSIS

#2575
20120058127
2012-03-08

PAR2 agonists for use in the treatment or prevention of influenza virus type A infections

#2576
20120046640
2012-02-23

Coating Comprising An Elastin-Based Copolymer

#2577
20120045502
2012-02-23

Antagonists of MUC1

#2578
20120034252
2012-02-09

COMPOSITIONS AND METHODS FOR INDUCING AN IMMUNE RESPONSE

#2579
20120034164
2012-02-09

TRUNCATED CAR PEPTIDES AND METHODS AND COMPOSITIONS USING TRUNCATED CAR PEPTIDES

#2580
20120034163
2012-02-09

NON-INVASIVE TOOLS FOR DETECTING VULNERABLE ATHEROSCLEROTIC PLAQUES

#2581
20120028913
2012-02-02

Peptides for inhibiting chemokine binding to chemokine receptors

#2582
20120028912
2012-02-02

Methods of modulating bromodomains

#2583
20120027805
2012-02-02

Controlled-released peptide formulations

#2584
20120027781
2012-02-02

Neuroprotective and neurorestorative method and compositions

#2585
20120021994
2012-01-26

Cancer antigen eEF2

#2586
20120015883
2012-01-19

Peptoid and synthetic oligomers, pharmaceutical compositions and methods of using same

#2587
20120014886
2012-01-19

Soothing cosmetic or pharmaceutical composition comprising a peptide which activates HMG-CoA reductase

#2588
20120010157
2012-01-12

Method of stimulating the motility of the gastrointestinal system using ipamorelin

#2589
20120010148
2012-01-12

COMBINATION THERAPIES USING NAP

#2590
20120009229
2012-01-12

Pharmaceutical compositions and related methods of delivery

#2591
20120004259
2012-01-05

Method of treatment or prophylaxis

#2592
20120003337
2012-01-05

HEALTH SUPPLEMENTS CONTAINING PHYTO-OESTROGENS, ANALOGUES OR METABOLITES THEREOF

#2593
20120003300
2012-01-05

Composition Comprising Vascular Endothelial Growth Factor (VEGF) for the Treatment of Hair Loss

#2594
20110319321
2011-12-29

Mammalian colostrum derived nanopeptides for broadspectrum viral and recurrent infections with a method of isolation thereof

#2595
20110318433
2011-12-29

Soothing pharmaceutical or cosmetic composition comprising a peptide that activates HMG-CoA reductase

#2596
20110318429
2011-12-29

Uses of an immunomodulatory protein (GMI) from

#2597
20110318408
2011-12-29

HLA CLASS I A2 TUMOR ASSOCIATED ANTIGEN PEPTIDES AND VACCINE COMPOSITIONS

#2598
20110318364
2011-12-29

Nonapeptide with anti-tumour activity

#2599
20110318329
2011-12-29

Method of treatment or prophylaxis

#2600
20110312898
2011-12-22

PROPHYLACTIC / THERAPEUTIC AGENT FOR CANCER

#2601
20110312897
2011-12-22

CATHEPSIN L PROTEOLYTICALLY PROCESSES HISTONE H3 DURING MOUSE EMBRYONIC STEM CELL DIFFERENTIATION

#2602
20110311621
2011-12-22

PHARMACEUTICAL COMPOSITIONS AND METHODS OF DELVERY

#2603
20110311563
2011-12-22

Synthetic antigenic peptides and lipopeptides derived from subsp.

#2604
20110306565
2011-12-15

HYALURONIC ACID CONTAINING COMPOSITIONS FOR TREATMENT OF WOUNDS, SCARS, POST-SURGICAL ADHESION FORMATION

#2605
20110306561
2011-12-15

COMPLEMENT C3a DERIVED DIMERIC PEPTIDES AND USES THEREOF

#2606
20110305782
2011-12-15

METHODS OF CHOLESTEROL REDUCTION USING ISOFLAVONES

#2607
20110305641
2011-12-15

Compositions and methods for treatment of angiogenesis-associated ocular disorders

#2608
20110305632
2011-12-15

PROCESS FOR THE PREPARATION OF ASYMMETRICAL BIS(THIOSEMICARBAZONES)

#2609
20110300199
2011-12-08

Cosmetic or pharmaceutical peptides containing uncoded amino acids and their use in the treatment and/or care of the skin, mucous membranes, or scalp

#2610
20110293516
2011-12-01

Compositions and methods of use of targeting peptides against placenta and adipose tissues

#2611
20110288010
2011-11-24

Utilization of peptides as active ingredients for slimming

#2612
20110287416
2011-11-24

Methylation detection of MGMT

#2613
20110281806
2011-11-17

Peptides for preventing or treating liver damage

#2614
20110281802
2011-11-17

COMPOSITION FOR TREATMENT AND PREVENTION OF HAIR LOSS AND PREMATURE GRAYING OF HAIR

#2615
20110280903
2011-11-17

IMMUNOSTIMULATORY COMBINATIONS

#2616
20110280833
2011-11-17

Peptides, derivatives and analogs thereof, and methods of using same

#2617
20110275562
2011-11-10

Inhibition of gliadin peptides

#2618
20110274709
2011-11-10

T-cell immunogens derived from anti-viral proteins and methods of using same

#2619
20110269695
2011-11-03

NOVEL ANTI-AGING PEPTIDES AND COSMETIC AND/OR PHARMACEUTICAL COMPOSITION CONTAINING SAME

#2620
20110269679
2011-11-03

INHIBITORS OF AMYLOID FIBRIL FORMATION AND USES THEREOF

#2621
20110269113
2011-11-03

Method of inhibiting biomaterial-induced procoagulant activity using complement inhibitors

#2622
20110263817
2011-10-27

METAL-BINDING COMPOUNDS AND USES THEREFOR

#2623
20110262400
2011-10-27

PROBIOTIC BACTERIAL MOLECULES AND THEIR USE IN METHODS TO TREAT/PREVENT INFECTION BY HARMFUL BACTERIA AND TO PROVIDE NUTRITIONAL HEALTH

#2624
20110257095
2011-10-20

PHARMACEUTICAL COMPOSITIONS AND RELATED METHODS OF DELIVERY

#2625
20110256136
2011-10-20

Complement inhibitors for treatment of injury from intracerebral hemorrhage

#2626
20110250284
2011-10-13

Nanoparticles for Use as Synthetic Platelets and Therapeutic Agent Delivery Vehicles

#2627
20110250180
2011-10-13

CCN3 peptides and analogs thereof for therapeutic use

#2628
20110245180
2011-10-06

Modified peptide that reduces pain in peripheral neuropathy

#2629
20110245149
2011-10-06

Methods to prevent and treat diseases

#2630
20110244015
2011-10-06

IMPLANTABLE DEVICE FOR THE DELIVERY OF OCTREOTIDE AND METHODS OF USE THEREOF

#2631
20110243845
2011-10-06

Somatostatin analogs with inhibitory activity to growth hormone release

#2632
20110237507
2011-09-29

Methods of protecting against apoptosis using lipopeptides

#2633
20110237492
2011-09-29

TREATMENT OF DISEASES AND CONDITIONS MEDIATED BY INCREASED PHOSPHORYLATION

#2634
20110236453
2011-09-29

Treatment of biofilms

#2635
20110236414
2011-09-29

Bacterial Polysaccharide-Polypeptide Conjugate Compositions

#2636
20110236405
2011-09-29

COAGULATION FACTOR MODULATION FOR CONTROLLING TRANSPLANT ORGAN SIZE

#2637
20110236384
2011-09-29

DIRECT DRUG DELIVERY SYSTEM BASED ON THERMALLY RESPONSIVE BIOPOLYMERS

#2638
20110230423
2011-09-22

THERAPY AND MEDICAMENT USING INTEGRIN LIGANDS FOR TREATING CANCER

#2639
20110230417
2011-09-22

Treatment of diseases and conditions mediated by increased phosphorylation

#2640
20110230415
2011-09-22

Method for controlling fibrosis and other pathological deposits in tissues comprising administering a GHRP-6 composition

#2641
20110223167
2011-09-15

COMBINATION THERAPY USING RECEPTOR TYROSINE KINASE INHIBITORS AND ANGIOGENESIS INHIBITORS

#2642
20110218149
2011-09-08

Treatment of kidney disorders with VIP fragments

#2643
20110213293
2011-09-01

Ligands to radiation-induced molecules

#2644
20110213122
2011-09-01

Obtaining cocoa extracts rich in bioactive peptides with ACE and PEP enzyme inhibitory activity

#2645
20110212887
2011-09-01

METHODS OF TREATING OBESITY USING ENTEROSTATIN

#2646
20110212882
2011-09-01

Uses of kappa opioid synthetic peptide amides

#2647
20110212075
2011-09-01

SCREENING METHOD FOR POLYMORPHIC MARKERS IN HTRA1 GENE IN NEURODEGENERATIVE DISORDERS

#2648
20110207677
2011-08-25

Use of cell-permeable peptide inhibitors of the JNK signal transduction pathway for the treatment of chronic or non-chronic inflammatory digestive diseases

#2649
20110201987
2011-08-18

COMBINATION THERAPY FOR PREVENTING OR TREATING ALZHEIMER'S DISEASE, AND KIT THEREFOR

#2650
20110201544
2011-08-18

Compositions and methods for inhibiting the interaction between CFTR and CAL

#2651
20110201543
2011-08-18

USE OF TIGHT JUNCTION ANTAGONISTS IN THE TREATMENT OF ACUTE LUNG INJURY AND ACUTE RESPIRATORY DISTRESS

#2652
20110201541
2011-08-18

Tissue occluding agent comprising an IEIKIEIKIEIKI peptide

#2653
20110195043
2011-08-11

Dimeric Smac mimetics

#2654
20110190138
2011-08-04

Methods and compositions for treating conditions

#2655
20110189290
2011-08-04

Compositions comprising capture peptides for A β-amyloid peptide

#2656
20110189263
2011-08-04

Peptides that target dorsal root ganglion neurons

#2657
20110189221
2011-08-04

NOVEL ANTIVIRAL COMPOUNDS FROM MARINE EXTRACTS

#2658
20110189206
2011-08-04

Antibody Targeting Through a Modular Recognition Domain

#2659
20110189199
2011-08-04

METHODS FOR P2RY5 MEDIATED REGULATION OF HAIR GROWTH AND MUTANTS THEREOF

#2660
20110189126
2011-08-04

Compositions containing interleukin-1 and peptides

#2661
20110183416
2011-07-28

Method of modulating the proliferation of medullary thyroid carcinoma cells

#2662
20110182989
2011-07-28

Peptide compositions and therapeutic uses thereof

#2663
20110182814
2011-07-28

Plectin-1 targeted agents for detection and treatment of pancreatic ductal adenocarcinoma

#2664
20110178025
2011-07-21

Amidated Dopamine Neuron Stimulating Peptides for CNS Dopaminergic Upregulation

#2665
20110178022
2011-07-21

Modified peptides as potent inhibitors of the PSD-95/NMDA receptor interaction

#2666
20110178021
2011-07-21

OPIORPHIN FOR USE AS A PSYCHOSTIMULANT AGENT

#2667
20110177528
2011-07-21

METHODS FOR DETECTING AND INHIBITING ANGIOGENESIS

#2668
20110177103
2011-07-21

Compositions and methods for the diagnosis and treatment of tumor

#2669
20110177069
2011-07-21

Inducer of chondrocyte proliferation and differentiation

#2670
20110177027
2011-07-21

COMBINATION THERAPY USING ANTI-ANGIOGENIC AGENTS AND TNFalpha

#2671
20110171243
2011-07-14

Compounds for treating amyloidoses

#2672
20110171175
2011-07-14

INHIBITORS OF SERINE PROTEASES

#2673
20110166653
2011-07-07

Medical devices

#2674
20110165229
2011-07-07

Compositions and methods for treatment

#2675
20110165228
2011-07-07

Compositions and methods for treatment

#2676
20110165117
2011-07-07

Immunogenic peptides and methods of use

#2677
20110165083
2011-07-07

Peptides that home to tumor lymphatic vasculature and methods of using same

#2678
20110165064
2011-07-07

Methods and compositions related to clot-binding compounds

#2679
20110160139
2011-06-30

Composition for improving brain function and method for improving brain function

#2680
20110152200
2011-06-23

Methods and compositions for inhibition of BCL6 repression

#2681
20110152179
2011-06-23

Method of treating HIV in drug resistant non plasma viral reservoirs with monomeric DAPTA

#2682
20110144029
2011-06-16

Model Systems and Materials for the Study and Treatment of Neurodegenerative Diseases

#2683
20110144023
2011-06-16

Nano cancer barrier device (NCBD) to immobilize and inhibit the division of metastic cancer stem cells

#2684
20110144020
2011-06-16

TREATMENT OF INFECTIONS AND OTHER DISORDERS

#2685
20110143992
2011-06-16

Methods and Compositions Related to GHS-R Antagonists

#2686
20110142881
2011-06-16

Transcutaneous delivery of therapeutic agents

#2687
20110142837
2011-06-16

Method Of Treating Acute Respiratory Distress Syndrome

#2688
20110136747
2011-06-09

Use of tight junction antagonists to treat inflammatory bowl disease

#2689
20110135741
2011-06-09

Sustained-release composition and method for producing the same

#2690
20110135661
2011-06-09

TREATMENT AND PREVENTION OF DRY AGE-RELATED MACULAR DEGENERATION BY ACTIVATING CD36

#2691
20110135656
2011-06-09

Method of treating cancer

#2692
20110135643
2011-06-09

Methods and compositions for prostate cancer immunotherapy

#2693
20110124584
2011-05-26

Compositions and methods for treating diseases

#2694
20110124550
2011-05-26

THYMOSIN BETA 4 PROMOTES WOUND REPAIR

#2695
20110123437
2011-05-26

COMBINATORIAL THERAPIES FOR THE TREATMENT OF NEOPLASIAS USING THE OPIOID GROWTH FACTOR RECEPTOR

#2696
20110118334
2011-05-19

Antisense antiviral compound and method for treating influenza viral infection

#2697
20110118175
2011-05-19

Competitive inhibitors of invariant chain expression and/or ectopic clip binding

#2698
20110110922
2011-05-12

Wound healing peptides and methods of use thereof

#2699
20110105386
2011-05-05

USE OF ANTIMICROBIAL POLYMERS FOR RE-SENSITIZATION OF MICROORGANISMS UPON EMERGENCE OF RESISTANCE TO ANTI-MICROBIAL AGENTS

#2700
20110104226
2011-05-05

Peptides having binding affinity to an antibody which recognizes an epitope on an α1 loop 2 or β2 loop 1 of an adrenoreceptor